Home » Stocks » MNMD

Mind Medicine (MindMed), Inc. (MNMD)

Stock Price: $3.23 USD 0.24 (8.03%)
Updated May 14, 2021 4:00 PM EDT - Market closed
After-hours: $3.49 +0.26 (8.05%) May 14, 7:59 PM
Market Cap 940.50M
Revenue (ttm) n/a
Net Income (ttm) -35.34M
Shares Out 326.13M
EPS (ttm) -0.10
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 14
Last Price $3.23
Previous Close $2.99
Change ($) 0.24
Change (%) 8.03%
Day's Open 3.08
Day's Range 3.06 - 3.33
Day's Volume 6,498,337
52-Week Range 0.29 - 5.77

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

NEW YORK, May 14, 2021 /PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (DE: MMQ) ("MindMed" or the "Company") is pleased to announce that it has appointed Dr. Sarah Y. Vinson a...

14 hours ago - PRNewsWire

NEW YORK, May 14, 2021 /PRNewswire/ -- Mind Medicine (MindMed) Inc. ("MindMed'' or the "Company") (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ), a leading psychedelic medicine biotech company, has announced its ...

15 hours ago - PRNewsWire

Mind Medicine Inc (NASDAQ: MNMD) was started to address mental wellness, CEO and co-founder J.R. Rahn told Benzinga's Global Small Cap Conference Thursday.

1 day ago - Benzinga

NEW YORK, May 13, 2021 /PRNewswire/ -- MindMed (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ), a leading psychedelic-inspired medicine company has appointed Peter Mack PhD as Vice President of Pharmaceutical Deve...

1 day ago - PRNewsWire

As the market gets back to normal, it's a great time to explore the pharma stocks that got lost in the vaccine frenzy of the past year. The post 7 of the Best Pharma Stocks to Buy Now appeared first on ...

Other stocks mentioned: ALLK, HZNP, IBRX, IMAB, SAGE, SWTX
3 days ago - InvestorPlace

Psychedelics could be a game-changer for millions struggling with mental health. Here are some of the top ways to trade psychedelic stocks.

Other stocks mentioned: CLXPF, CMPS
1 week ago - InvestorPlace

NEW YORK, May 5, 2021 /PRNewswire/ -- Mind Medicine (MindMed) Inc. ("MindMed" or the "Company") (NASDAQ: MNMD) (NEO: MMED), (DE: MMQ), a leading psychedelic-inspired medicine company announces the launc...

1 week ago - PRNewsWire

On April 29, shares of Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) hit a wall of resistance at the $4.30 level. Since then, they have been in a freefall.

Other stocks mentioned: MVIS
1 week ago - Benzinga

Investors searching for Tesla-like price appreciation should consider these seven growth stocks for real returns. The post 7 Runaway Growth Stocks That Could Be the Next Tesla appeared first on Investor...

Other stocks mentioned: AI, BABA, BYDDF, HYFM, JD, NIO
1 week ago - InvestorPlace

It may be time to sell GameStop Corp. (NYSE: GME), Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), and Archer-Daniels-Midland Company (NYSE: ADM) and the reasons why will be outlined below. On Jan 28, Redd...

Other stocks mentioned: ADM, GME
1 week ago - Benzinga

Shares of Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) have hit a wall of resistance at the $4.30 level. This has put a top on the stock.

2 weeks ago - Benzinga

Remember when marijuana used to be taboo? Back when Cheech & Chong – a comedy duo who tapped into the height of the cultural weed zeitgeist during the ‘70s – pushed the envelope to further their drug-fu...

2 weeks ago - InvestorPlace

Mind Medicine (MindMed) Inc (NASDAQ:MNMD) (NEO: MMED), a leading medicine biotech company in psychedelics, this week began trading on the Nasdaq exchange. In light of the momentous occasion, Benzinga sp...

2 weeks ago - Benzinga

Psychedelics Medicine Company MindMed Makes Nasdaq Debut

YouTube video

MindMed CEO J.R. Rahn spoke to Cheddar about the psychedelic mental health therapy company taking the big step forward going public on the Nasdaq exchange.

2 weeks ago - Cheddar

MindMed (MNMD) stock isn't doing so hot with shares taking a beating on the first day of trading at their new home on the Nasdaq. The post MNMD Stock: A MindMed Buzz Kill as the Psychedelic Shares Tank ...

2 weeks ago - InvestorPlace

MindMed stock rose in its Nasdaq listing debut on Tuesday, making it the latest psychedelic drug developer to land on a major U.S. exchange.  The post MindMed Stock Climbs In Nasdaq Debut As Psychedelic...

2 weeks ago - Investors Business Daily

Mind Medicine Inc. (NASDAQ:MNMD) commenced trading its subordinate voting shares on The Nasdaq Capital Market Tuesday, under the ticker symbol “MNMD,” as previously announced.   The psychedelic medicine...

2 weeks ago - Benzinga

NEW YORK, April 27, 2021 /PRNewswire/ -- MindMed (Nasdaq: MNMD, NEO: MMED, DE: MMQ), a leading psychedelic medicine biotech company, is pleased to announce the start of trading on The Nasdaq Capital Mar...

Other stocks mentioned: MMEDF
2 weeks ago - PRNewsWire

Clinical-stage psychedelic medicine and biotech company Mind Medicine Inc (OTC:MMEDF), also known as MindMed, is surging again Monday ahead of its Nasdaq debut. The company's mission is "to discover, de...

Other stocks mentioned: MMEDF
2 weeks ago - Benzinga

As MNMD stock gets ready for its Nasdaq uplisting, the company is seeing rapid gains pushing its price to new highs. The post MNMD Stock: 9 Things to Know Before MindMed Hits the Nasdaq on April 27 appe...

Other stocks mentioned: MMEDF
2 weeks ago - InvestorPlace

Magic mushrooms and other hallucinogens are becoming a big business.

Other stocks mentioned: CMPS, MMEDF
2 weeks ago - The Motley Fool

MindMed (MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting to the Nasdaq Exchange from the OTC Markets. The post MMEDF Stock: 7 Things to Know About Psychedelic Biotec...

Other stocks mentioned: MMEDF
3 weeks ago - InvestorPlace

Mind Medicine Inc. (NEO: MMED) (OTCQB:MMEDF) (DE: MMQ) confirmed Monday it will commence trading on the Nasdaq Capital Market under the ticker symbol “MNMD” on April 27th. The psychedelic medicine biote...

Other stocks mentioned: MMEDF
3 weeks ago - Benzinga

NEW YORK, April 23, 2021 /PRNewswire/ -- MindMed (Nasdaq: MNMD) (NEO: MMED) (DE: MMQ), a leading psychedelic medicine biotech company, announced today that the Company's subordinate voting shares have b...

Other stocks mentioned: MMEDF
3 weeks ago - PRNewsWire

About MNMD

Mind Medicine (MindMed) Inc., a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The company is headquartered in New York, New York.

Industry
Biotechnology
IPO Date
Mar 3, 2020
Stock Exchange
2020-03-03
Ticker Symbol
MNMD
Full Company Profile